Truveta news For media inquiries, please email news@truveta.com Clinical trials: Introducing real-time trial design, optimization, and evidence generation January 27, 2026 Why I’m joining Truveta January 26, 2026 Introducing Truveta Live Link January 13, 2026 Truveta recognized on national and Seattle LinkedIn Top Startup 2025 lists October 29, 2025 Transparency is the new standard: FDA’s view on regulatory-grade RWE October 3, 2025 Truveta adds new precision device data September 23, 2025 Celebrating 5 years of Saving Lives with Data September 22, 2025 Johns Hopkins builds research community to explore new frontiers in health using Truveta Data September 10, 2025 1 2 … 10 Next » Truveta in the news Children who miss early vaccines more likely to not get the MMR shot by age 2 Women with PCOS seek relief in weight-loss drugs Weight Loss Drugs Now Account For 1 In 14 Prescriptions, Study Says FDA to streamline approvals for generic biological drugs in latest move targeting health costs See all articles Recent press releases Truveta Research study published in Contraception advances understanding of women’s health and clinical guideline adoption February 2, 2026 Truveta launches real-time clinical trials solution to accelerate study design, enrollment, and evidence generation January 27, 2026 Truveta deepens oncology and scientific leadership with appointment of Johnathan Lancaster, MD, PhD as President and Chief Scientific Officer January 26, 2026 Truveta launches Truveta Live Link January 13, 2026 See all press releases Images Truveta logo Format: PNG Truveta Data Map Format: PNG Truveta Health System Members Format: PNG
Clinical trials: Introducing real-time trial design, optimization, and evidence generation January 27, 2026
Johns Hopkins builds research community to explore new frontiers in health using Truveta Data September 10, 2025
Truveta Research study published in Contraception advances understanding of women’s health and clinical guideline adoption February 2, 2026
Truveta launches real-time clinical trials solution to accelerate study design, enrollment, and evidence generation January 27, 2026
Truveta deepens oncology and scientific leadership with appointment of Johnathan Lancaster, MD, PhD as President and Chief Scientific Officer January 26, 2026